51-44 Vote: Dr. Erica Schwartz Takes Helm of CDC Amid 3 Major Outbreaks

After nearly a year without a permanent director, the CDC finally has a leader—but Dr. Erica Schwartz steps into a public health agency besieged by workforce losses and simultaneous outbreaks that test its response capabilities. For health systems relying on CDC guidance, her approach to evidence-based policy in a politically charged environment will directly shape national preparedness and disease surveillance.

The U.S. Senate has confirmed Dr. Erica Schwartz as the new director of the Centers for Disease Control and Prevention by a 51-44 vote on August 5, 2026, ending nearly a year of leadership vacancy at the nation’s premier public health agency. The vote fell almost entirely along party lines, underscoring the deep political divisions surrounding vaccine policy and the role of science in the second Trump administration. Schwartz inherits an agency that has been gutted by thousands of layoffs, resignations, and leadership departures during a period of mounting public health threats, including surges in measles, cyclosporiasis outbreaks, and an Ebola outbreak in the Democratic Republic of the Congo and Uganda.

“

After nearly a year without a permanent director, the CDC finally has a leader—but Dr.

The prior permanent director was fired roughly a year earlier in a dispute with Health and Human Services Secretary Robert F. Kennedy Jr. over vaccine policy, leaving the CDC without stable leadership during a time when agency morale and scientific credibility were already under strain. Schwartz’s confirmation hearing in July before the Senate Health, Education, Labor and Pensions Committee drew sharp questioning from Senator Bill Cassidy, a Republican, who pressed her on whether she would maintain independence from Secretary Kennedy on vaccines. Cassidy ultimately voted to advance her nomination after reviewing her testimony and speaking with colleagues, stating on July 23 that he was “confident that she knows what she is doing and will stand against those who do not.” His vote, along with other Republicans, provided the margin of passage, though many Democrats and Independents remained openly skeptical that Schwartz would uphold evidence-based policies if they conflicted with the administration’s positions.

Schwartz’s ascension comes at a perilous moment for the CDC. The agency is concurrently managing domestic measles outbreaks, a cyclosporiasis surge linked to contaminated produce, and supporting international efforts against an Ebola outbreak in central Africa. The loss of thousands of employees—through voluntary resignations and forced layoffs—has severely diminished the agency’s rapid response capacity. Dr. Demetre Daskalakis, a former top CDC official who resigned in the previous year, captured the sentiment of many public health professionals: “I really wish her luck in her new role, but I would also say, it’s not about the job, it’s about the public health mission – and that needs to be her focus.”